All You Need to Know About Cardlytics (CDLX) Rating Upgrade to Buy
Cardlytics (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cardlytics, Inc. (CDLX) Q3 2025 Earnings Call Transcript
Cardlytics, Inc. ( CDLX ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Nick Lynton - Chief Legal & Privacy Officer and Secretary Amit Gupta - CEO & Director Alexis DeSieno - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Capital Markets, LLC, Research Division Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Q3 2025 Cardlytics, Inc. Earnings Conference Call. [Operator Instructions] This call is being recorded on November 5, 2025.
Cardlytics, Inc. (CDLX) Q2 2025 Earnings Call Transcript
Cardlytics, Inc. (NASDAQ:CDLX ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants Alexis DeSieno - Chief Financial Officer Amit Gupta - CEO & Director Nick Lynton - Chief Legal & Privacy Officer and Secretary Conference Call Participants Cal Bartyzal - Unidentified Company Jacob Michael Stephan - Lake Street Capital Markets, LLC, Research Division Robert James Coolbrith - Evercore ISI Institutional Equities, Research Division Operator Good afternoon, ladies and gentlemen, and welcome to the Second Quarter 2025 Cardlytics, Inc. Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, August 6 of 2025.
Cardlytics (CDLX) Reports Q2 Loss, Misses Revenue Estimates
Cardlytics (CDLX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.15 per share a year ago.
Cardlytics: Underrecognized Margin Recovery; Strong Buy Reiterated
We maintain our Strong Buy on Cardlytics and issue a PT of $6, despite the near-term revenue reset and slower monetization from new partners. The Amex channel is a game-changer, offering high-margin, immediate profitability with minimal incremental OpEx, supporting a clear path to EBITDA recovery. EBP and platform diversification are driving structural margin expansion, de-risking revenue and opening new high-engagement verticals for scalable growth.
Cardlytics, Inc. (CDLX) Q1 2025 Earnings Call Transcript
Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Nick Lynton - Chief Legal and Privacy Officer Amit Gupta - Chief Executive Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Luke Horton - Northland Capital Markets Robert Coolbrith - Evercore Cal Bartyzal - Craig-Hallum Operator Ladies and gentlemen, thank you for standing by, and welcome to the Cardlytics Inc. Q1 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, May 7, 2025.
Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates
Cardlytics (CDLX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.09 per share a year ago.
Cardlytics, Inc. (CDLX) Q4 2024 Earnings Call Transcript
Cardlytics, Inc. (NASDAQ:CDLX ) Q4 2024 Results Conference Call March 12, 2025 5:00 PM ET Company Participants Nick Lynton - Chief Legal & Privacy Officer Amit Gupta - Chief Executive Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Luke Horton - Northland Securities Kyle Peterson - Needham Cal Bartyzal - Craig-Hallum Robert Coolbrith - Evercore ISI Operator Good afternoon, ladies and gentlemen, and welcome to the Cardlytics Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all lines are in listen-only mode.
Cardlytics: Short-Term Headwinds Drive Long-Term Success
Cardlytics, Inc. offers an asymmetric investment opportunity for those who can handle stock price volatility and slow business progress. Recent issues with ad deliveries have impacted revenue and market sentiment but positioned the company for long-term success. The shift to engagement-based pricing is expected to drive broader platform adoption.
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics Inc For Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / January 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Cardlytics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders With Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Cardlytics (CDLX)
Cardlytics (CDLX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
